HAYWARD, Calif.--(BUSINESS WIRE)--
Impax Laboratories, Inc. (NASDAQ: IPXL) today announced
that the Company will present at the Cowen & Company 33rd
Annual Health Care Conference on Wednesday, March 6, at 8:00 a.m.
Eastern Standard Time. The conference will be held at The Boston
Marriott Copley Place, Boston, MA.
Individuals may listen to the live or an archived presentation made at
the conference, which will be posted in the investor relations section
of the Company’s web site at www.impaxlabs.com.
This presentation will be archived on the Company’s web site for 30 days.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. (Impax) is a technology based specialty
pharmaceutical company applying its formulation expertise and drug
delivery technology to the development of controlled-release and
specialty generics in addition to the development of central nervous
system disorder branded products. Impax markets its generic products
through its Global Pharmaceuticals division and markets its branded
products through the Impax Pharmaceuticals division. Additionally, where
strategically appropriate, Impax develops marketing partnerships to
fully leverage its technology platform and pursues partnership
opportunities that offer alternative dosage form technologies, such as
injectables, nasal sprays, inhalers, patches, creams and ointments.
Impax Laboratories is headquartered in Hayward, California, and has a
full range of capabilities in its Hayward, Philadelphia and Taiwan
facilities. For more information, please visit the Company's Web site
at: www.impaxlabs.com.
Source: Impax Laboratories, Inc.